MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2023-10-30
DOI
10.1080/10428194.2023.2275532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content
- (2022) Merve Uslu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- BML‐260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability
- (2022) Esra Albayrak et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Small molecule‐mediated modulation of ubiquitination and neddylation improves HSC function ex vivo
- (2021) Esra Albayrak et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Development of Small Molecule MEIS Inhibitors that modulate HSC activity
- (2020) Raife Dilek Turan et al. Scientific Reports
- FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
- (2019) Hitoshi Kiyoi et al. CANCER SCIENCE
- c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression
- (2018) Merve Aksoz et al. CURRENT CANCER DRUG TARGETS
- Leukemic stem cells: identification and clinical application
- (2017) Diana Hanekamp et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Analysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population
- (2016) Madara Kreile et al. Archives of Medical Science
- Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact
- (2016) Kevin Rouault-Pierre et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Hypoxia and Hypoxia-Inducible Factors in Leukemias
- (2016) Margaux Deynoux et al. Frontiers in Oncology
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells
- (2012) F. Kocabas et al. BLOOD
- Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
- (2011) Yin Wang et al. Cell Stem Cell
- Leukemia stem cells
- (2011) Eike C. Buss et al. INTERNATIONAL JOURNAL OF CANCER
- MEIS1, PREP1, and PBX4 Are Differentially Expressed in Acute Lymphoblastic Leukemia: Association of MEIS1 Expression with Higher Proliferation and Chemotherapy Resistance
- (2011) Judith A Rosales-Aviña et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche
- (2010) Tugba Simsek et al. Cell Stem Cell
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- A role for MEIS1 in MLL-fusion gene leukemia
- (2008) A. R. Kumar et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started